ClinicalTrials.gov record
No Longer Available No phase listed Expanded access

Intermediate-Sized Expanded Access Study

ClinicalTrials.gov ID: NCT05597436

Public ClinicalTrials.gov record NCT05597436. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 14, 2026, 4:44 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Expanded Access Protocol of Intravenous Trehalose Injection 90.5 mg/mL Treatment of Patients With Amyotrophic Lateral Sclerosis

Study identification

NCT ID
NCT05597436
Recruitment status
No Longer Available
Study type
Expanded access
Phase
Not listed
Lead sponsor
Seelos Therapeutics, Inc.
Industry
Enrollment
Not listed

Conditions and interventions

Interventions

  • Trehalose Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Not listed
Primary completion
Not listed
Completion
Not listed
Last update posted
Sep 1, 2025

United States locations

U.S. sites
21
U.S. states
17
U.S. cities
19
Facility City State ZIP Site status
Barrow Neurological Institute Phoenix Arizona 85013
University of California, Irvine Orange California 92697
University of California, San Francisco San Francisco California 94115
University of Colorado Aurora Colorado 80045
Hospital for Special Care New Britain Connecticut 06053
George Washington University Washington D.C. District of Columbia 20052
Holy Cross Hospital - Phil Smith Neuroscience Institute Fort Lauderdale Florida 33308
Nova Southeastern University Fort Lauderdale Florida 33328
Saint Alphonsus Regional Medical Center Boise Idaho 83706
University of Iowa Hospitals and Clinics Iowa City Iowa 52242
University of Maryland School of Medicine Baltimore Maryland 21201
Sean M. Healey & AMG Center for ALS Neurological Clinical Research Institute, Massachusetts General Hospital Boston Massachusetts 02114
Beth Israel Deaconess Medical Center Boston Massachusetts 02215
Spectrum Health/Corewell Health Grand Rapids Michigan 49503
University of Minnesota Minneapolis Minnesota 55455
Washington University School of Medicine St Louis Missouri 63110
SUNY Upstate Medical University Syracuse New York 13210
Lehigh Valley Hospital Allentown Pennsylvania 18105
Thomas Jefferson University Philadelphia Pennsylvania 19107
Texas Neurology, P.A.-Neal Site:769 Dallas Texas 75206
Virginia Commonwealth University Clinical Research Unit Richmond Virginia 23298

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05597436, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 1, 2025 · Synced May 14, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05597436 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →